Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma ; volume:73 ; number:10 ; day:2 ; month:8 ; year:2024 ; pages:1-13 ; date:10.2024
Cancer immunology immunotherapy ; 73, Heft 10 (2.8.2024), 1-13, 10.2024
- Creator
-
Wu, Huantong
Xu, Zhuofan
Qi, Maoyang
Liu, Penghao
Zhang, Boyan
Wang, Zhenglin
Chen, Ge
Liu, Xiaohai
Liu, Junqi
Wei, Wei
Duan, Wanru
Chen, Zan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-024-03756-9
- URN
-
urn:nbn:de:101:1-2411292104051.794360989216
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wu, Huantong
- Xu, Zhuofan
- Qi, Maoyang
- Liu, Penghao
- Zhang, Boyan
- Wang, Zhenglin
- Chen, Ge
- Liu, Xiaohai
- Liu, Junqi
- Wei, Wei
- Duan, Wanru
- Chen, Zan
- SpringerLink (Online service)
Other Objects (12)
Establishing guidelines for CAR-T cells: challenges and considerations
Engineering CAR-T cells
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
New development in CAR-T cell therapy
Recent advances in CAR-T cell engineering
CAR-T Cell Therapy for Solid Tumors
Dynamic fine-tuning of CAR-T cell therapy
CAR-T cells in multiple myeloma: current status
Engineering Efficient CAR‐T Cells via Electroactive Nanoinjection
Dynamic fine-tuning of CAR-T cell therapy
CAR-T cell combination therapies in hematologic malignancies
Nanobody-based CAR-T cells for cancer immunotherapy
Establishing guidelines for CAR-T cells: challenges and considerations
Engineering CAR-T cells
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
New development in CAR-T cell therapy
Recent advances in CAR-T cell engineering
CAR-T Cell Therapy for Solid Tumors
Dynamic fine-tuning of CAR-T cell therapy
CAR-T cells in multiple myeloma: current status
Engineering Efficient CAR‐T Cells via Electroactive Nanoinjection
Dynamic fine-tuning of CAR-T cell therapy
CAR-T cell combination therapies in hematologic malignancies
Nanobody-based CAR-T cells for cancer immunotherapy
Establishing guidelines for CAR-T cells: challenges and considerations
Engineering CAR-T cells
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
New development in CAR-T cell therapy
Recent advances in CAR-T cell engineering
CAR-T Cell Therapy for Solid Tumors
Dynamic fine-tuning of CAR-T cell therapy
CAR-T cells in multiple myeloma: current status
Engineering Efficient CAR‐T Cells via Electroactive Nanoinjection
Dynamic fine-tuning of CAR-T cell therapy
CAR-T cell combination therapies in hematologic malignancies